All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Potential Regulatory Effect of mir-182-3p on Osteosarcoma by Targeting Early B-Cell Factor 2

Author(s): H. JIANG, F. LOU, WEN GUO AND Y. LI*
Departments of orthopedics, Departments of Oncology, Taizhou People’s Hospital Affiliated to Medical College of The Nantong University, Taizhou, Jiangsu 225300, P. R. China

Correspondence Address:
Departments of orthopedics, Departments of Oncology, Taizhou People’s Hospital Affiliated to Medical College of The Nantong University, Taizhou, Jiangsu 225300, P. R. China, E-mail: fanggufan68024342@163.com


This study investigated the role of miR-182-3p in osteosarcoma. The effect of the miR-182-3p expression on cell function and the regulatory signal changes of Early B-cell Factor 2 targeted by miR-182-3p were studied in the osteosarcoma cell line in vitro. miR-182-3p was downregulated in both osteosarcoma patients and osteosarcoma cell line. The overexpression of miR-182-3p resulted in increased apoptosis of osteosarcoma cells and decreased migration and invasion of osteosarcoma cells. In addition, miR-182-3p regulated the messenger RNA stability of early B-cell factor 2 y directly binding to the 3 prime untranslated region of Early B-Cell Factor 2, which was a key regulator of osteosarcoma cell apoptosis. Overexpression of Early B-Cell Factor 2 could inhibit the apoptosis of osteosarcoma cells and promote the migration and invasion of osteosarcoma cells effectively. At the same time, overexpression of Early B-Cell Factor 2 could alleviate the phenotype induced by miR-182-3p. miR-182-3p was a tumor suppressing microRNA in osteosarcoma. Its function was realized by inhibiting Early B-Cell Factor 2. These results provided a new therapeutic target for metastatic osteosarcoma and a better understanding of the molecular regulation of Early B-Cell Factor 2.

Full-Text | PDF

 
 
Google scholar citation report
Citations : 69022

Indian Journal of Pharmaceutical Sciences received 69022 citations as per google scholar report